Status: current, Defined. Date: 30-Apr 2022. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 5034023015 | Product containing cefuroxime and clavulanic acid (medicinal product) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 5034024014 | Cefuroxime- and clavulanic acid-containing product | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Cefuroxime- and clavulanic acid-containing product | Is a | Clavulanic acid-containing product | true | Inferred relationship | Some | ||
| Cefuroxime- and clavulanic acid-containing product | Is a | Cefuroxime-containing product | true | Inferred relationship | Some | ||
| Cefuroxime- and clavulanic acid-containing product | Plays role | Antibacterial therapeutic role | true | Inferred relationship | Some | ||
| Cefuroxime- and clavulanic acid-containing product | Has active ingredient | Cefuroxime | true | Inferred relationship | Some | 1 | |
| Cefuroxime- and clavulanic acid-containing product | Has active ingredient | Clavulanic acid | true | Inferred relationship | Some | 2 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Cefuroxime and clavulanic acid only product | Is a | True | Cefuroxime- and clavulanic acid-containing product | Inferred relationship | Some | |
| Cefuroxime- and clavulanic acid-containing product in oral dose form | Is a | True | Cefuroxime- and clavulanic acid-containing product | Inferred relationship | Some |
This concept is not in any reference sets
FHIR